We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-17.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10B
AUM Growth
-$4.54B
Cap. Flow
-$1.63B
Cap. Flow %
-16.3%
Top 10 Hldgs %
18.24%
Holding
2,308
New
654
Increased
395
Reduced
491
Closed
723

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$173M
2
EBAY icon
eBay
EBAY
+$149M
3
ZTS icon
Zoetis
ZTS
+$127M
4
TFX icon
Teleflex
TFX
+$108M
5
TMO icon
Thermo Fisher Scientific
TMO
+$98.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.96%
2 Consumer Discretionary 18.46%
3 Technology 13.47%
4 Financials 11.57%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFI
1351
DELISTED
Armstrong Flooring, Inc.
AFI
$84K ﹤0.01%
58,803
-93,607
-61% -$290K
FISI icon
1352
Financial Institutions
FISI
$830M
$83K ﹤0.01%
4,593
+1,246
+37% +$33.4K
RMTI icon
1353
Rockwell Medical
RMTI
$27.6M
$83K ﹤0.01%
+369
New +$105K
RMG.WS
1354
DELISTED
RMG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stoc
RMG.WS
$83K ﹤0.01%
133,331
EWN icon
1355
iShares MSCI Netherlands ETF
EWN
$557M
$82K ﹤0.01%
+3,170
New +$98.5K
GDXJ icon
1356
VanEck Junior Gold Miners ETF
GDXJ
$6.99B
$82K ﹤0.01%
2,903
-45,993
-94% -$1.75M
CRSP icon
1357
CRISPR Therapeutics
CRSP
$4.68B
$81K ﹤0.01%
1,917
-457
-19% -$23.6K
LITE icon
1358
Lumentum
LITE
$50.7B
$81K ﹤0.01%
+1,099
New +$86.5K
ROST icon
1359
Ross Stores
ROST
$80.5B
$81K ﹤0.01%
928
+903
+3,612% +$96.4K
ETN icon
1360
Eaton
ETN
$150B
$80K ﹤0.01%
1,034
-66,452
-98% -$6.09M
VDE icon
1361
Vanguard Energy ETF
VDE
$9.72B
$80K ﹤0.01%
+2,097
New +$133K
GWRE icon
1362
Guidewire Software
GWRE
$13.3B
$79K ﹤0.01%
+992
New +$104K
FFWM
1363
DELISTED
First Foundation Inc
FFWM
$78K ﹤0.01%
+7,643
New +$113K
TRVG
1364
trivago
TRVG
$387M
$76K ﹤0.01%
10,472
-27,563
-72% -$313K
BNY
1365
Bank of New York Mellon
BNY
$106B
$74K ﹤0.01%
2,192
-128,764
-98% -$5.41M
KMI icon
1366
Kinder Morgan
KMI
$70.3B
$74K ﹤0.01%
5,352
-577
-10% -$11K
KRTX
1367
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$74K ﹤0.01%
+1,034
New +$88.4K
MGI
1368
DELISTED
MoneyGram International, Inc. New
MGI
$74K ﹤0.01%
+56,171
New +$118K
CMPR icon
1369
Cimpress
CMPR
$2.43B
$73K ﹤0.01%
+1,365
New +$138K
ZLAB icon
1370
Zai Lab
ZLAB
$2.1B
$73K ﹤0.01%
1,420
IQ icon
1371
iQIYI
IQ
$1.21B
$71K ﹤0.01%
+3,967
New +$89.1K
NTGR icon
1372
NETGEAR
NTGR
$663M
$71K ﹤0.01%
3,095
-1,220
-28% -$27.4K
ED icon
1373
Consolidated Edison
ED
$41.3B
$70K ﹤0.01%
900
+890
+8,900% +$78K
IWB icon
1374
iShares Russell 1000 ETF
IWB
$47.9B
$70K ﹤0.01%
+492
New +$83.2K
RRR icon
1375
Red Rock Resorts
RRR
$3.87B
$70K ﹤0.01%
+8,134
New +$161K

Similar funds

Marshall Wace's Q1 2020 Portfolio in Review

As of Q1 2020, Marshall Wace held 2,308 positions worth $10B, down 31% from $14.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace withdrew a net $1.63B in Q1 2020, closing 723 positions and reducing 491 holdings. Its most notable exit was eBay, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Marshall Wace opened a new position in Bank of Montreal worth $53.5M.

  • Marshall Wace's largest Q1 2020 buy was Bank of Montreal: 1,072,183 shares worth $53.5M.
  • Marshall Wace added most to Fidelity National Information Services in Q1 2020, an estimated $146M increase.
  • Marshall Wace's biggest Q1 2020 reduction was Boston Scientific, cutting an estimated $173M.
  • Marshall Wace fully exited eBay in Q1 2020, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 18% of its $10B portfolio in Q1 2020.
  • Marshall Wace opened 654 new positions and closed 723 in Q1 2020.
  • Marshall Wace's portfolio value fell 31% quarter-over-quarter to $10B.

Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.